Erectile dysfunction as a harbinger for increased cardiometabolic risk

International Journal of Impotence Research
Kevin BillupsR A Williams

Abstract

In August 2003, the Minority Health Institute (MHI) convened an Expert Advisory Panel of cardiologists and urologists to design a new practice model algorithm that uses erectile dysfunction (ED) as a clinical tool for early identification of men with systemic vascular disease. The MHI algorithm noted ED as a marker for the presence of cardiovascular disease and suggested that ED may well be a cardiovascular risk equivalent warranting aggressive secondary prevention management strategies, even in the absence of other cardiac or peripheral vascular symptoms. The MHI algorithm stipulates that all men 25 years of age and older should be asked about ED as a routine part of the cardiovascular history during any office visit. The presence of ED should prompt an aggressive assessment for occult vascular disease; many men with erectile difficulty would benefit from early, aggressive management of cardiovascular risk factors with both lifestyle modification and pharmacotherapy to achieve optimal target goals under the existing treatment guidelines. Since publication of the algorithm in 2005, additional research studies have further supported the advisory panel recommendations.

References

Nov 14, 1997·Clinical Pharmacology and Therapeutics·C M SteinA J Wood
Jun 13, 1998·International Journal of Urology : Official Journal of the Japanese Urological Association·M M BaşarZ Akalin
Mar 23, 2000·Cardiovascular Research·J Y JeremyK M Naseem
Jun 15, 2000·The New England Journal of Medicine·T F Lue
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Sep 12, 2001·Circulation·D E Jorenby
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Apr 27, 2002·Heart Disease·L T ClarkJ T Wright
Jun 27, 2002·Expert Opinion on Pharmacotherapy·R W A JonesJ Y Jeremy
Jul 2, 2002·The American Journal of Geriatric Cardiology·Mary McGrae McDermott
Aug 24, 2002·The Journal of Gender-specific Medicine : JGSM : the Official Journal of the Partnership for Women's Health at Columbia·Janice B Schwartz
Sep 21, 2002·Lancet·Duncan M Geddes
Mar 15, 2003·BMJ : British Medical Journal·Paul BurnsAndrew W Bradbury
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jul 18, 2003·The American Journal of Cardiology·Cranford L Scott
Aug 23, 2003·European Urology·Piero MontorsiClaude C Schulman
Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Apr 10, 2004·The Journal of Clinical Hypertension·Gary H Gibbons
Mar 4, 2005·International Journal of Impotence Research·E VicariA E Calogero
Jul 16, 2005·The American Journal of Cardiology·John B KostisRidwan Shabsigh
Sep 16, 2005·International Journal of Impotence Research·E VicariA E Calogero
Jan 18, 2006·JAMA : the Journal of the American Medical Association·Ian M ThompsonCharles A Coltman
Jan 21, 2006·The Journal of Sexual Medicine·Francesco Montorsi
Jan 21, 2006·The Journal of Sexual Medicine·Tina C BansalRichard W Nesto

❮ Previous
Next ❯

Citations

Sep 6, 2012·Endocrine·Giorgio GandagliaFrancesco Montorsi
Dec 8, 2010·Cardiology in Review·David ShinJulius M Gardin
Aug 2, 2013·International Journal of Impotence Research·C V OztekinM Cetinkaya
Sep 10, 2013·European Urology·Giorgio GandagliaCharalambos Vlachopoulos
May 12, 2012·Journal of Mental Health·Alphonsus U IdungOluyinka S Akinbami
Feb 12, 2009·The Journal of Sexual Medicine·Taben M HaleMichael A Adams
Mar 17, 2009·The Journal of Sexual Medicine·Li-Ming Jin
Oct 31, 2014·Sexual Medicine·Abdulla Al NaimiAbdulla Al Ansari
Jan 14, 2016·Endocrine·Nicola CarettaCarlo Foresta
Jun 16, 2010·The Journal of Sexual Medicine·Yung-Chin LeeShu-Pin Huang
Dec 23, 2011·The Journal of Sexual Medicine·Hui Meng TanChristopher C K Ho
Aug 6, 2014·The Journal of Sexual Medicine·Alessandra BarassiGian Vico Melzi d'Eril
May 12, 2010·The Journal of Sexual Medicine·Giovanni CoronaM Maggi
Jun 23, 2009·The Journal of Sexual Medicine·Andre B AraujoJohn B McKinlay
Feb 2, 2010·Journal of the American College of Cardiology·Andre B AraujoJohn B McKinlay
Aug 29, 2012·Dermato-endocrinology·Marc Sorenson, William B Grant
May 12, 2015·Disease Markers·Alessandra BarassiMassimiliano Marco Corsi Romanelli
Feb 14, 2015·Current Urology Reports·Nikhil GuptaBruce R Gilbert
Mar 24, 2017·International Journal of Urology : Official Journal of the Japanese Urological Association·Yukihito Higashi
Jan 6, 2010·The Physician and Sportsmedicine·William O BrantJames F Smith
Jul 1, 2013·Journal of Clinical Urology·Jas Kalsi, Asif Muneer
Dec 20, 2014·Postgraduate Medicine·Eduardo RandrupAllison Feibus
Jul 16, 2009·Current Opinion in Obstetrics & Gynecology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.